These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24310589)

  • 41. Evaluation about wettability, water absorption or swelling of excipients through various methods and the correlation between these parameters and tablet disintegration.
    Yang B; Wei C; Yang Y; Wang Q; Li S
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1417-1425. PubMed ID: 29557692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
    Adeoye O; Alebiowu G
    Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants.
    Battu SK; Repka MA; Majumdar S; Madhusudan RY
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1225-32. PubMed ID: 18058319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A methodological evaluation and predictive in silico investigation into the multi-functionality of arginine in directly compressed tablets.
    ElShaer A; Kaialy W; Akhtar N; Iyire A; Hussain T; Alany R; Mohammed AR
    Eur J Pharm Biopharm; 2015 Oct; 96():272-81. PubMed ID: 26255158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functionalized calcium carbonate as a novel pharmaceutical excipient for the preparation of orally dispersible tablets.
    Stirnimann T; Di Maiuta N; Gerard DE; Alles R; Huwyler J; Puchkov M
    Pharm Res; 2013 Jul; 30(7):1915-25. PubMed ID: 23604923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
    Zimmer Ł; Kasperek R; Poleszak E
    Polim Med; 2014; 44(4):231-5. PubMed ID: 25932904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential Use of Magnesium Oxide as an Excipient to Maintain the Hardness of Orally Disintegrating Tablets during Unpackaged Storage.
    Sakamoto T; Kachi S; Nakamura S; Yuasa H
    Chem Pharm Bull (Tokyo); 2019; 67(3):284-288. PubMed ID: 30828006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expedited Development of Diphenhydramine Orally Disintegrating Tablet through Integrated Crystal and Particle Engineering.
    Wang C; Hu S; Sun CC
    Mol Pharm; 2017 Oct; 14(10):3399-3408. PubMed ID: 28825961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Latent structure analysis of the process variables and pharmaceutical responses of an orally disintegrating tablet.
    Hayashi Y; Oshima E; Maeda J; Onuki Y; Obata Y; Takayama K
    Chem Pharm Bull (Tokyo); 2012; 60(11):1419-25. PubMed ID: 22878814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlled-Release Fine Particles Prepared by Melt Adsorption for Orally Disintegrating Tablets.
    Shiino K; Oshima T; Sonoda R; Kimura SI; Itai S; Iwao Y
    Chem Pharm Bull (Tokyo); 2019; 67(10):1152-1159. PubMed ID: 31582635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of drying methods on the physicochemical and compressional characteristics of Okra powder and the release properties of its metronidazole tablet formulation.
    Bakre LG; Jaiyeoba KT
    Arch Pharm Res; 2009 Feb; 32(2):259-67. PubMed ID: 19280157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
    Stange U; Führling C; Gieseler H
    J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
    Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
    Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
    Petrovick GF; Kleinebudde P; Breitkreutz J
    Eur J Pharm Biopharm; 2018 Jan; 122():137-145. PubMed ID: 29106946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
    Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
    Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of Coprocessed Chitin-Calcium Carbonate as Multifunctional Tablet Excipient for Direct Compression, Part 2: Tableting Properties.
    Chaheen M; Bataille B; Yassine A; Belamie E; Sharkawi T
    J Pharm Sci; 2019 Oct; 108(10):3319-3328. PubMed ID: 31145923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.
    Gulsun T; Ozturk N; Kaynak MS; Vural I; Sahin S
    Pharmazie; 2017 Jul; 72(7):389-394. PubMed ID: 29441935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New advances in the characterization of lyophilised orally disintegrating tablets.
    Vanbillemont B; Everaert H; De Beer T
    Int J Pharm; 2020 Apr; 579():119153. PubMed ID: 32084575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of Formulation and Process of Lyophilised Orally Disintegrating Tablet (ODT) Using Novel Amino Acid Combination.
    AlHusban F; ElShaer AM; Kansara JH; Smith AM; Grover LM; Perrie Y; Mohammed AR
    Pharmaceutics; 2010 Jan; 2(1):1-17. PubMed ID: 27721339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation and optimization of fast disintegrating tablets of isosorbide dinitrate using lyophilization method for oral drug delivery.
    Alami-Milani M; Salatin S; Nasiri E; Jelvehgari M
    Ther Deliv; 2021 Jul; 12(7):523-538. PubMed ID: 34098729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.